Diartis Pharmaceuticals Receives New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=259b1db1-9e11-460c-8996-b47f9f642665&Preview=1
Date
2/16/2011
Company Name
Diartis Pharmaceuticals
Mailing Address
500 Ellis St. Mountain View, CA 94043
Company Description
Diartis is a biotechnology company founded to develop therapeutics for the treatment of metabolic diseases that address both significant unmet medical needs as well as large market opportunities.
Website
http://www.diartispharma.com
Transaction Type
Venture Equity
Transaction Amount
Undisclosed
Transaction Round
Undisclosed
Proceeds Purposes
The company will focus on moving this exciting compound rapidly through early clinical development. Given the dramatic rise in the number of people with type 2 diabetes, there is a significant market need for a longer acting form of the GLP-1 analog exenatide.
M&A Terms
Venture Investor
Index Ventures
Venture Investor
Undisclosed